Skip to main content

Table 7 List of currently approved biosimilar monoclonal antibodies in oncology

From: What do oncologists need to know about biosimilar products?

Region Active substance Brand name (pharmaceutical company) Approved indications in oncology Approval date
India Trastuzumab CANmab (Biocon)/Hertraz (Mylan) HER2-positive breast cancer 25/11/2013
South Korea Trastuzumab Herzuma (Celltrion) HER2-positive breast cancer
Advanced (metastatic) gastric cancer
15/01/2014
Russia Trastuzumab HERtiCAD (Biocad) Breast cancer 20/01/2016
Russia Rituximab AcellBia (CSJC biocad) CD20-positive non-Hodgkin’s B-cell lymphoma 25/05/2014
  1. HER2 human epidermal growth factor receptor 2